Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells

Experimental Cell Research

Volumn 254, Issue 2, 2000, Pages 287-298

  Battle, Traci E ^a   Levine, Roy A ^a   Yen, Andrew ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

blr1; Cell cycle; Leukemic myeloid cell differentiation; MAPK; Retinoids

Indexed keywords

BLR1 PROTEIN; GENE PRODUCT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 0034141569     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4766     Document Type: Article

References (70)

1. Gudas L. J. Retinoids and vertebrate development. J. Biol. Chem. 269:1994;15399-15402.
2. de Luca L. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5:1991;2924-2933.
3. Warrell R. P. Jr., Frankel S. R., Miller W. H., Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreff A., Tafudi A., Jakubowski A., Gabrilove J., Gordon M., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324:1991;1385-1393.
4. Castaigne S., Chomienne C., Daniel M. T., Fenaux P., Berger R., Degos L. All-trans retinoic acid as a differentiation therapy in acute promyelocytic leukemias. I. Clinical results. Blood. 76:1990;1704-1709.
5. Huang M. E., Ye Y. C., Chen S. R., Chai J. R., Lu J. X., Zhoa L., Gu L. J., Wang Z. Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567-572.
6. Meyskens F. L. Jr., Surwit E., Moon T. E., Childers J. M., Davis J. R., Dorr R. T., Johnson C. S., Alberts D. S. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans retinoic acid: A randomized trial. J. Natl. Cancer Inst. 86:1994;539-543.
7. Kelly J. W., Sabto J., Gurr F. W. Retinoids to prevent skin cancer in organ transplant recipients. Lancet. 338:1991;1407.
8. Kraemer K., DiGiovanna J., Moshell A., Tarone R., Peck G. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N. Engl. J. Med. 318:1988;1633-1637.
9. Lotan R. Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers. Environ. Health Perspect. 105:1997;985-988.
10. Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J., Dimery I. W., Brown B. W., Goepfert H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323:1990;795-801.
11. Chambon P. The retinoid signaling pathway: Molecular and genetic analysis. Semin. Cell Biol. 5:1994;115-125.
12. Mangelsdorf D. J., Kazukiko U., Evans R. M. The retinoid receptors. Sporn M. B., Roberts A., Goodman D. S. The Retinoids. 1994;Raven Press, New York.
13. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
14. Mangelsdorf D. J., Evans R. M. Retinoid receptors as transcription factors. Yamamoto K. R., McKnight S. Transcriptional Regulation. 1991;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
15. Yen A., Forbes M. E., Varvayanis S., Tykocinski M. L., Groger R. K., Platko J. D. c-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J. Cell. Physiol. 157:1993;379-391.
16. Yen A., Forbes M., de Gala G., Fishbaugh J. Control of HL-60 differentiation lineage specificity: A late event occurring after precommitment. Cancer Res. 47:1987;129-134.
17. Yen A., Sturgill R., Varvayanis S. Increasing c-FMS expression decreases retinoic acid concentration needed to cause cell differentiation and RB hypophosphorylation. Cancer Res. 57:1997;2020-2028.
18. Yen A., Roberson M. S., Varvayanis S., Lee A. T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58:1998;163-3172.
19. Grande A., Manfredini R., Tagliafico E., Balestri R., Pizzanelli M., Papa S., Zucchini P., Bonsi L., Bagnara G., Torelli U., Ferrari S. All-trans retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp. Hematol. 23:1995;117-125.
20. Hsu H. C., Yang K., Kharbanda S., Clinton S., Datta R., Stone R. M. All-trans retinoic acid induced monocyte growth factor receptor c-FMS gene expression in HL-60 leukemia cells. Leukemia. 7:1993;458-462.
21. Tkatch L. S., Rubin K. A., Ziegler S. F., Tweardy D. J. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J. Leukocyte Biol. 57:1995;964-971.
22. Bories D., Raynal M. C., Solomon D., Darzynkiewicz Z., Cayre Y. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyleocytic leukemia cells. Cell. 59:1989;959-968.
23. Iri T., Homma Y., Ohaka Y., Robishaw J. D., Katada T., Bourne H. R. Potentiation of Gi-mediated phospholipase C activation by retinoic acid in HL-60 cells: Possible role of Gγ2. J. Biol. Chem. 270:1995;5901-5908.
24. Matikainen S., Hurme M. Comparison of retinoic acid and phorbol myristate acetate as inducers of monocytic differentiation. Intl. J. Cancer. 57:1994;98-103.
25. Nishikawa N., Omay S. B., Toyod H., Tawara I., Shima H., Nagao M., Hemmings B. A., Mumby M. D., Deguchi K. Expression of the catalytic and regulatory subunits of protein phosphatase type 2A may be differentially modulated during retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res. 54:1994;4879-4884.
26. Larsson L. G., Pettersson M., Oberg F., Nilsson K., Luescher B. Expression of mad, mxi1, max, and c-myc during induced differentiation of hematopoietic cells: Opposite regulation of mad and c-myc. Oncogene. 9:1994;1247-1252.
27. Katagiri K., Katagiri T., Koyama Y., Morikawa M., Yamaoto T., Yoshida T. Expression of SRC family genes during monocytic differentiation of HL-60 cells. J. Immunol. 146:1991;701-707.
28. Brackman D., Lund-Johansen F., Aarskog D. Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. Leukocyte Res. 19:1995;57-64.
29. Drach J., Zhao S., Malavasi F., Mehta K. Rapid induction of CD38 antigen on myeloid leukemia cells by all-trans retinoic acid. Biochem. Biophys. Res. Commun. 195:1993;545-550.
30. Kim K. Y., Kweon K. R., Lee M. S., Kwak S. T., Kim K. E., Hwang B. D., Lim K. Reduced level of octamer binding transcription factor (Oct-1) is correlated with H2B histone gene repression during differentiation of HL-60 cells by all-trans retinoic acid. Biochem. Biophys. Res. Commun. 213:1995;616-624.
31. Nagy L., Thomazy V., Chandraratna R., Heyman R., Davies P. Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leukocyte Res. 20:1996;499-505.
32. Mengubas K., Riordan F. A., Hoffbrand A. V., Wickremasinghe R. G. Coordinated downregulation of bcl-2 and bax expression during granulocytic and macrophage-like differentiation of the HL60 promyelocytic leukaemia cell line. FEBS Lett. 394:1996;356-360.
33. Yen A., Forbes M. E. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine. Cancer Res. 50:1990;1411-1420.
34. Burn T., Petrovick M., Hohaus S., Rollins B., Tenen D. Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood. 84:1994;2776-2783.
35. Liang P., Averboukh L., Pardee A. B. Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and opitmization. Nucleic Acids Res. 21:1993;3269-3275.
36. Liang P., Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
37. Rollins B., Stier P., Ernst T., Wong G. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9:1989;4687-4695.
38. Dobner T., Wolf I., Emrich T., Lipp M. Differentiation-specific expression of a novel G-protein-coupled receptor from Burkitt's lymphoma. Eur. J. Immunol. 22:1992;2795-2799.
39. Barella L., Loetshcer M., Tobler A., Baggiolini M., Moser B. Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochem. J. 309:1995;773-779.
40. Nagata Y., Takahashi N., Davis R., Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood. 92:1998;1859-1869.
41. Cowley S., Paterson H., Kemp P., Marshall C. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
42. Knall C., Young S., Nick J., Mette Buhl A., Worthen S. G., Johnson G. L. Interleukin-8 regulation of the ras/raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271:1996;2832-2838.
43. Clerk A., Michael A., Sugden P. H. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G-protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy. J. Cell Biol. 142:1998;523-535.
44. Buhl A. M., Osawa S., Johnson G. L. Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor. J. Biol. Chem. 270:1995;19828-19832.
45. Hawes B. E., van Biesen T., Koch W. J., Luttrell L. M., Lefkowitz R. J. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;17148-17153.
46. Faure M., Voyno-Yasenetskaya T. A., Bourne H. R. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269:1994;7851-7854.
47. Honda Z., Takano T., Gotoh Y., Nishida E., Ito K., Shimizu T. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J. Biol. Chem. 269:1994;2307-2315.
48. ras. Proc. Natl. Acad. Sci. USA. 91:1994;12706-12710.
49. Worthen G. S., Avdi N., Buhl A. M., Suzuki N., Johnson G. L. FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase. J. Clin. Invest. 94:1994;815-823.
50. Alblas J., Van Corven E. J., Hordijk P. L., Milligan G., Moolenaar W. H. Gi-mediated activation of the p21ras-mitogen-activated protein kinase pathway by alpha 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268:1993;22235-22238.
51. Kaiser E., Förster R., Wolf I., Ebensperger C., Keuhl W. M., Lipp M. The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues. Eur. J. Immunol. 23:1993;2532-2539.
52. Emrich T., Förster R., Lipp M. Transmembrane topology of the lymphocyte-specific G-protein-coupled receptor BLR1: Analysis by flow cytometry and immunocytochemistry. Cell. Mol. Biol. France. 40:1994;413-419.
53. Förster R., Wolf I., Kaiser E., Lipp M. Selective expression of the murine homologue of the G protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum. Cell. Mol. Biol. France. 40:1994;381-387.
54. Förster R., Emrich T., Kremmer E., Lipp M. Expression of the G protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood. 84:1994;830-840.
55. Förster R., Mattis A. E., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 87:1996;1037-1047.
56. Gunn M. D., Ngo V. N., Ansel K. M., Ekland E. H., Cyster J. G., Williams L. T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 391:1998;799-803.
57. Legler D. F., Loetscher M., Roos R. S., Clark-Lewis I., Baggiolini M., Moser B. B-cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187:1998;655-660.
58. Wolf I., Pevzner V., Kaiser W., Bernhardt G., Claudio E., Siebenlist U., Förster R., Lipp M. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-κB directs expression of the homing receptor BLR1 to mature B cells. J. Biol. Chem. 273:1998;28831-28836.
59. Craig R., Frankfurt O., Sakagami H., Takeda K., Bloch A. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. Cancer Res. 44:1984;2421-2429.
60. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein MAP kinase cascade may be required for differentiation of PC12 cells: Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:1992;255-352.
61. Marshall C. J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
62. iα in HL60 cells. FEBS Lett. 221:1987;81-86.
63. Uhing R. J., Polakis P. G., Snyderman R. Isolation of GTP-binding proteins from myeloid HL-60 cells. Identification of two pertussis toxin substrates. J. Biol. Chem. 262:1987;15575-15579.
64. Amatruda T. T. III, Stelle D. A., Slepak V. Z., Simon M. I. Gα16, a G protein α subunit specifically expressed in hematopoietic cells. Proc. Natl. Acad. Sci. USA. 88:1991;5587-5591.
65. Crespo P., Xu N., Simonds W. F., Gutkind J. S. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature. 369:1994;418-420.
66. i2, transduce mitogenic signals. J. Cell. Biochem. 54:1994;415-422.
67. Tago K., Kaziro Y., Satoh T. Functional involvement of mSos in interleukin-3 and thrombin stimulation of the Ras, mitogen-activated protein kinase pathway in BaF3 murine hematopoietic cells. J. Biochem. Tokyo. 123:1998;659-667.
68. Luo Y., Kokkonen G. C., Wang X., Neve K. A., Roth G. S. D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J. Neurochem. 71:1998;980-990.
69. Wan Y., Kurosaki T., Huang X. Tyrosine kinases in activation of the MAP kinase cascade by G protein-coupled receptors. Nature. 380:1996;541-544.
70. Yen A., Williams M., Platko J. D., Der C., Hisaka M. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. Eur. J. Cell Biol. 65:1994;103-113.